Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $29.0 million.

  • Gossamer Bio's Cash from Investing Activities rose 163.59% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.4 million, marking a year-over-year increase of 453.79%. This contributed to the annual value of $29.0 million for FY2024, which is 126.15% up from last year.
  • As of FY2024, Gossamer Bio's Cash from Investing Activities stood at $29.0 million, which was up 126.15% from -$111.0 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Cash from Investing Activities ranged from a high of $215.3 million in FY2020 and a low of -$117.4 million during FY2021.
  • In the last 3 years, Gossamer Bio's Cash from Investing Activities had a median value of -$1.0 million in 2022 and averaged -$27.7 million.
  • In the last 5 years, Gossamer Bio's Cash from Investing Activities soared by 246.35% in 2020 and then crashed by 10,621.74% in 2023.
  • Gossamer Bio's Cash from Investing Activities (Yearly) stood at $215.3 million in 2020, then plummeted by 154.53% to -$117.4 million in 2021, then skyrocketed by 99.12% to -$1.0 million in 2022, then slumped by 10,621.74% to -$111.0 million in 2023, then surged by 126.15% to $29.0 million in 2024.